Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI.

Landau SM, Horng A, Fero A, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative..

Neurology. 2016 Apr 12;86(15):1377-85. doi: 10.1212/WNL.0000000000002576.

PMID:
26968515
2.

Comparison of Visual and Quantitative Florbetapir F 18 Positron Emission Tomography Analysis in Predicting Mild Cognitive Impairment Outcomes.

Schreiber S, Landau SM, Fero A, Schreiber F, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative..

JAMA Neurol. 2015 Oct;72(10):1183-90. doi: 10.1001/jamaneurol.2015.1633.

PMID:
26280102
3.

Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures.

Apostolova LG, Hwang KS, Avila D, Elashoff D, Kohannim O, Teng E, Sokolow S, Jack CR, Jagust WJ, Shaw L, Trojanowski JQ, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative..

Neurology. 2015 Feb 17;84(7):729-37. doi: 10.1212/WNL.0000000000001231.

4.

Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression.

Caroli A, Prestia A, Galluzzi S, Ferrari C, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen C, Wall AE, Carter SF, Schöll M, Choo IH, Grimmer T, Redolfi A, Nordberg A, Scheltens P, Drzezga A, Frisoni GB; Alzheimer's Disease Neuroimaging Initiative..

Neurology. 2015 Feb 3;84(5):508-15. doi: 10.1212/WNL.0000000000001209.

5.

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators..

N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.

6.

A community-based approach to trials of aerobic exercise in aging and Alzheimer's disease.

Vidoni ED, Van Sciver A, Johnson DK, He J, Honea R, Haines B, Goodwin J, Laubinger MP, Anderson HS, Kluding PM, Donnelly JE, Billinger SA, Burns JM.

Contemp Clin Trials. 2012 Nov;33(6):1105-16. doi: 10.1016/j.cct.2012.08.002.

7.

Predicting missing biomarker data in a longitudinal study of Alzheimer disease.

Lo RY, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative..

Neurology. 2012 May 1;78(18):1376-82. doi: 10.1212/WNL.0b013e318253d5b3.

8.

Predicting MCI outcome with clinically available MRI and CSF biomarkers.

Heister D, Brewer JB, Magda S, Blennow K, McEvoy LK; Alzheimer's Disease Neuroimaging Initiative..

Neurology. 2011 Oct 25;77(17):1619-28. doi: 10.1212/WNL.0b013e3182343314.

9.

Longitudinal change of biomarkers in cognitive decline.

Lo RY, Hubbard AE, Shaw LM, Trojanowski JQ, Petersen RC, Aisen PS, Weiner MW, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative..

Arch Neurol. 2011 Oct;68(10):1257-66. doi: 10.1001/archneurol.2011.123.

PMID:
21670386
10.

Repeatability and reproducibility of landmarks--a three-dimensional computed tomography study.

Titiz I, Laubinger M, Keller T, Hertrich K, Hirschfelder U.

Eur J Orthod. 2012 Jun;34(3):276-86. doi: 10.1093/ejo/cjq190.

PMID:
21566086
11.

Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort.

Kim S, Swaminathan S, Shen L, Risacher SL, Nho K, Foroud T, Shaw LM, Trojanowski JQ, Potkin SG, Huentelman MJ, Craig DW, DeChairo BM, Aisen PS, Petersen RC, Weiner MW, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative..

Neurology. 2011 Jan 4;76(1):69-79. doi: 10.1212/WNL.0b013e318204a397.

12.

Discovering genetic associations with high-dimensional neuroimaging phenotypes: A sparse reduced-rank regression approach.

Vounou M, Nichols TE, Montana G; Alzheimer's Disease Neuroimaging Initiative..

Neuroimage. 2010 Nov 15;53(3):1147-59. doi: 10.1016/j.neuroimage.2010.07.002.

PMID:
20624472
13.

Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment.

Schott JM, Bartlett JW, Barnes J, Leung KK, Ourselin S, Fox NC; Alzheimer's Disease Neuroimaging Initiative investigators..

Neurobiol Aging. 2010 Aug;31(8):1452-62, 1462.e1-2. doi: 10.1016/j.neurobiolaging.2010.04.011.

14.

Effects of BDNF Val66Met polymorphism on brain metabolism in Alzheimer's disease.

Xu C, Wang Z, Fan M, Liu B, Song M, Zhen X, Jiang T; Alzheimer's Disease Neuroimaging Initiative..

Neuroreport. 2010 Aug 23;21(12):802-7. doi: 10.1097/WNR.0b013e32833ccaf4.

15.

Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.

Wolk DA, Dickerson BC; Alzheimer's Disease Neuroimaging Initiative..

Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10256-61. doi: 10.1073/pnas.1001412107.

16.

A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly.

Ho AJ, Stein JL, Hua X, Lee S, Hibar DP, Leow AD, Dinov ID, Toga AW, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, Stephan DA, DeCarli CS, DeChairo BM, Potkin SG, Jack CR Jr, Weiner MW, Raji CA, Lopez OL, Becker JT, Carmichael OT, Thompson PM; Alzheimer's Disease Neuroimaging Initiative..

Proc Natl Acad Sci U S A. 2010 May 4;107(18):8404-9. doi: 10.1073/pnas.0910878107.

17.

Voxelwise genome-wide association study (vGWAS).

Stein JL, Hua X, Lee S, Ho AJ, Leow AD, Toga AW, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, Dechairo BM, Potkin SG, Weiner MW, Thompson P; Alzheimer's Disease Neuroimaging Initiative..

Neuroimage. 2010 Nov 15;53(3):1160-74. doi: 10.1016/j.neuroimage.2010.02.032.

18.

A robust method to estimate the intracranial volume across MRI field strengths (1.5T and 3T).

Keihaninejad S, Heckemann RA, Fagiolo G, Symms MR, Hajnal JV, Hammers A; Alzheimer's Disease Neuroimaging Initiative..

Neuroimage. 2010 May 1;50(4):1427-37. doi: 10.1016/j.neuroimage.2010.01.064.

19.

Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort.

Shen L, Kim S, Risacher SL, Nho K, Swaminathan S, West JD, Foroud T, Pankratz N, Moore JH, Sloan CD, Huentelman MJ, Craig DW, Dechairo BM, Potkin SG, Jack CR Jr, Weiner MW, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative..

Neuroimage. 2010 Nov 15;53(3):1051-63. doi: 10.1016/j.neuroimage.2010.01.042.

20.

Sex-dependent association of common variants of microcephaly genes with brain structure.

Rimol LM, Agartz I, Djurovic S, Brown AA, Roddey JC, Kähler AK, Mattingsdal M, Athanasiu L, Joyner AH, Schork NJ, Halgren E, Sundet K, Melle I, Dale AM, Andreassen OA; Alzheimer's Disease Neuroimaging Initiative..

Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):384-8. doi: 10.1073/pnas.0908454107.

Items per page

Supplemental Content

Loading ...
Support Center